Fungal Infection Testing + Diagnostics for Human Health

Since 2002, MiraVista Diagnostics has been developing and evolving our menu of diagnostic tests for fungal infections. We work with hospital labs, research university labs, government and municipal labs, physician practices, large reference labs and CROs across the country to detect, analyze and monitor a wide range of serious mycology infections that afflict their patients. This includes antigen and antibody detection tests for aspergillus, blastomyces dermatitidis, histoplasma capsulatum, coccidioides, cryptococcus and beta-D-glucan.

Accurate Test Results Lead to Better Patient Outcomes

MiraVista Diagnostics understands the critical role we play in the health care and health science continuum. Because we take that responsibility seriously, we are committed to partnering with clinicians to consistently deliver:

  • Superior clinical standards in testing accuracy and sensitivity
  • Rapid response and test results
  • Dedication to excellent client service and customer satisfaction
  • Direct access to our infectious disease experts
  • Quality assurance across our organization
  • Compliance with regulatory mandates and industry best practices
  • Continuous product and service improvement
Company News

MiraVista COVID-19 Annoucement

MiraVista is open and continues to provide critical diagnostic testing despite the impact COVID-19 has had on staffing. The health and welfare of our team is of critical importance. To limit the opportunity of exposure to COVID-19 for our entire…

MiraVista Diagnostics LLC has formed an Institutional Biosafety Committee (IBC)

In compliance with the National Institutes of Health Office of Science Policy (NIH OSP), MiraVista Diagnostics LLC has formed an Institutional Biosafety Committee (IBC) to review, approve and confirm that the company’s research involving recombinant/synthetic DNA complies with NIH guidelines….

Characterization of an Uncinocarpus Reesii-expressed Recombinant Tube Precipitin Antigen of Coccidioides Posadasii for Serodiagnosis

Early and accurate diagnosis of coccidioidomycosis, also known as Valley fever, is critical for appropriate disease treatment and management. Current serodiagnosis is based on the detection of patient serum antibodies that react with tube precipitin (TP) and complement fixation (CF)…

Peripheral Blood Smear Findings in a Kidney Transplant Recipient with Disseminated Histoplasmosis and Elevated Aspergillus Galactomannan.

We report a case of disseminated histoplasmosis in a renal transplant recipient who presented with a nodular pulmonary lesion and elevated serum and bronchoalveolar lavage (BAL) Aspergillus galatomannan. This almost led to an erroneous diagnosis of invasive aspergillosis since the…

ID Week: Advances in Diagnosis of Progressive Coccidioidomycosis

Dr. Joseph Wheat presenting Thursday, October 3, 2019 at ID Week Session Date: Thursday, October 3, 2019 Session Time: 12:15 PM – 1:30 PM Stop by poster 236 on October 3rd, 12:15PM – 1:30PM, to speak with Dr. Wheat. Event…

Saturday testing and shipments

Saturday testing and shipments We now accept specimens on Saturdays and offer Histoplasma antigen and Blastomyces antigen EIA tests on Saturdays.

  • vendor logo
  • vendor logo
  • vendor logo
  • vendor logo
  • vendor logo